Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.
about
Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549.Low Density Lipid Nanoparticles for Solid Tumor Targeting.Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution.Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in miceCorrelation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinomaRecombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.Serum proteins as drug carriers of anticancer agents: a review.A study of the influence of dexamethasone on lipid profile and enzyme lactate dehydrogenase.Learning from biology: synthetic lipoproteins for drug delivery.Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.Cytosolic delivery of LDL nanoparticle cargo using photochemical internalization.Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.Acute Myelogenous Leukemia Cells Secrete Factors that Stimulate Cellular LDL Uptake via Autocrine and Paracrine Mechanisms.Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy.Biological activities of phthalocyanines. XIII. The effects of human serum components on the in vitro uptake and photodynamic activity of zinc phthalocyanine.Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells.
P2860
Q34358025-87E12613-1EEA-4987-8FB3-B7C713D2B576Q35747597-CDCF3ECD-4A7A-45C5-862A-014C7C5688B2Q35779820-4AF54CEA-0D4C-4F59-B09C-8AB4B20A8EEEQ35977291-8F825B7E-5AF3-46B8-AF79-361221D301A1Q36081132-AC1F3534-2FDD-438A-9B37-565E1BC5F8B3Q36148570-96835ECA-14F5-457D-989B-3C983A9EEE91Q36985913-5F308B0C-3683-4378-84E3-A3F6F3239512Q37537586-A21FE572-33EF-4143-806A-9EE3B9878A9BQ37698044-CB771223-6B61-4082-8B7E-5EA889CA8E54Q38262882-0A63036D-B5AF-470B-B160-3DEE8F910DC7Q38548184-D3AA1E31-9EC0-43B5-80BC-5C14C33CF407Q39587660-689AF2E0-1A95-496F-85D8-293EFD2DE66AQ40175554-E32C29DF-7A48-4A0C-8E59-50D36F45A0E7Q41030491-609E3125-D551-4635-908D-8382FAA4AE7DQ41177935-4525E65B-38B7-44BE-964D-8F3BF5BA7780Q41560934-00E81B76-1D4F-482C-83F8-9BFAA07B6352Q42102018-6401B929-F6F0-40C7-99D7-D0DF6308CCD8
P2860
Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Low density lipoprotein for de ...... of a drug-lipoprotein complex.
@en
type
label
Low density lipoprotein for de ...... of a drug-lipoprotein complex.
@en
prefLabel
Low density lipoprotein for de ...... of a drug-lipoprotein complex.
@en
P2093
P2860
P356
P1476
Low density lipoprotein for de ...... of a drug-lipoprotein complex.
@en
P2093
Masquelier M
Peterson C
Sjöström B
Söderberg-Reid K
P2860
P2888
P304
P356
10.1038/BJC.1990.367
P407
P577
1990-11-01T00:00:00Z